- Home
- WSBC vs CORT Comparison
WSBC vs CORT Comparison
Compare WSBC & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WSBC | CORT |
|---|---|---|
| Founded | 1870 | 1998 |
| Country | | US |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.7B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | WSBC | CORT |
|---|---|---|
| Price | $36.42 | $39.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $39.00 | ★ $114.20 |
| AVG Volume (30 Days) | 466.7K | ★ 1.6M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.15% | N/A |
| EPS Growth | N/A | ★ 30.85 |
| EPS | N/A | ★ 0.62 |
| Revenue | N/A | ★ $675,040,000.00 |
| Revenue This Year | $7.92 | $23.03 |
| Revenue Next Year | $6.93 | $19.76 |
| P/E Ratio | ★ $16.36 | $64.49 |
| Revenue Growth | N/A | ★ 39.94 |
| 52 Week Low | $26.42 | $32.99 |
| 52 Week High | $38.10 | $117.33 |
Technical Indicators
Market Signals| Indicator | WSBC | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 55.09 | 40.86 |
| Support Level | $35.85 | $38.00 |
| Resistance Level | $37.67 | $41.92 |
| Average True Range (ATR) | 0.99 | 1.91 |
| MACD | -0.08 | 0.89 |
| Stochastic Oscillator | 55.56 | 34.66 |
Price Performance
Historical ComparisonAbout WSBC WesBanco Inc.
Wesbanco Inc is a bank holding company. Through its subsidiaries, it offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. The company's reportable segments are Community Banking, which derives key revenue, and Trust and Investment Services. The Community Banking segment offers various banking products and services through various delivery channels, including commercial demand, individual demand, and time deposit accounts; commercial, mortgage, and individual installment loans; and certain non-traditional offerings, such as insurance and securities brokerage services.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.